Thomas David Hull III Sells 213 Shares of Kewaunee Scientific Co. (NASDAQ:KEQU) Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) CEO Thomas David Hull III sold 213 shares of the firm’s stock in a transaction on Friday, March 21st. The stock was sold at an average price of $48.53, for a total transaction of $10,336.89. Following the completion of the transaction, the chief executive officer now directly owns 40,916 shares of the company’s stock, valued at approximately $1,985,653.48. This represents a 0.52 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Thomas David Hull III also recently made the following trade(s):

• On Monday, March 24th, Thomas David Hull III sold 3,000 shares of Kewaunee Scientific stock. The shares were sold at an average price of $45.63, for a total value of $136,890.00.
• On Friday, January 10th, Thomas David Hull III sold 1,368 shares of Kewaunee Scientific stock. The stock was sold at an average price of $60.08, for a total value of $82,189.44.
• On Thursday, December 26th, Thomas David Hull III sold 2,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $63.01, for a total value of $126,020.00.

Kewaunee Scientific Trading Down 9.7 %

Shares of Kewaunee Scientific stock opened at $40.60 on Wednesday. The stock has a market cap of $115.91 million, a PE ratio of 6.43 and a beta of 0.71. The firm has a fifty day moving average price of $56.95 and a 200 day moving average price of $47.55. Kewaunee Scientific Co. has a 1 year low of $30.82 and a 1 year high of $71.33. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.64 and a quick ratio of 2.13.

Kewaunee Scientific (NASDAQ:KEQU) last released its quarterly earnings data on Wednesday, March 12th. The technology company reported $1.09 earnings per share for the quarter. The business had revenue of $67.17 million during the quarter. Kewaunee Scientific had a return on equity of 25.83% and a net margin of 9.39%.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of KEQU. Bank of America Corp DE increased its holdings in shares of Kewaunee Scientific by 2,605.9% during the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock valued at $28,000 after purchasing an additional 443 shares in the last quarter. Jane Street Group LLC acquired a new position in shares of Kewaunee Scientific in the fourth quarter worth about $300,000. Marshall Wace LLP purchased a new stake in shares of Kewaunee Scientific during the 4th quarter worth about $736,000. Invesco Ltd. acquired a new stake in shares of Kewaunee Scientific during the 4th quarter valued at about $6,545,000. Finally, Wedbush Securities Inc. acquired a new stake in shares of Kewaunee Scientific during the 4th quarter valued at about $262,000. 32.69% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded shares of Kewaunee Scientific from a “buy” rating to a “hold” rating in a report on Friday, March 14th.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.